fluoxetine has been researched along with Gangliosidoses in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Gangliosidoses: A group of autosomal recessive lysosomal storage disorders marked by the accumulation of GANGLIOSIDES. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the LYSOSOMES. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adult GM2 gangliosidosis is a rare disorder that often presents with both neurological and psychiatric syndromes." | 2.38 | Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis. ( Kolodny, EH; Renshaw, PF; Schouten, R; Stern, TA; Welch, C, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Renshaw, PF | 1 |
| Stern, TA | 1 |
| Welch, C | 1 |
| Schouten, R | 1 |
| Kolodny, EH | 1 |
1 review available for fluoxetine and Gangliosidoses
| Article | Year |
|---|---|
Electroconvulsive therapy treatment of depression in a patient with adult GM2 gangliosidosis.
Topics: Adult; beta-N-Acetylhexosaminidases; Combined Modality Therapy; Depressive Disorder; Electroconvulsi | 1992 |